X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (3248) 3248
Publication (226) 226
Book Review (70) 70
Book Chapter (34) 34
Conference Proceeding (13) 13
Dissertation (2) 2
Magazine Article (2) 2
Journal / eJournal (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (1839) 1839
urology & nephrology (1784) 1784
index medicus (1618) 1618
detrusor overactivity (1369) 1369
female (1299) 1299
male (1049) 1049
overactive bladder (939) 939
urinary incontinence (826) 826
bladder (803) 803
middle aged (790) 790
urodynamics (685) 685
aged (660) 660
animals (620) 620
adult (607) 607
treatment outcome (519) 519
urology (466) 466
neurogenic detrusor overactivity (453) 453
urinary bladder, overactive - drug therapy (448) 448
incontinence (444) 444
double-blind (388) 388
women (375) 375
detrusor (367) 367
botulinum toxin (364) 364
urinary bladder, overactive - physiopathology (360) 360
urinary bladder (353) 353
urinary bladder - physiopathology (350) 350
medicine & public health (341) 341
efficacy (321) 321
urinary-incontinence (321) 321
rats (319) 319
urinary bladder - drug effects (317) 317
quality-of-life (303) 303
lower urinary-tract (294) 294
analysis (274) 274
symptoms (274) 274
care and treatment (271) 271
neurogenic bladder (270) 270
pharmacology & pharmacy (255) 255
quality of life (255) 255
aged, 80 and over (253) 253
prospective studies (253) 253
obstetrics & gynecology (248) 248
dysfunction (241) 241
botulinum toxins, type a - administration & dosage (223) 223
benign prostatic hyperplasia (221) 221
botulinum toxins, type a - therapeutic use (217) 217
detrusor instability (211) 211
voiding dysfunction (209) 209
urinary bladder - innervation (203) 203
muscarinic antagonists - therapeutic use (202) 202
urinary-tract symptoms (192) 192
bladder outlet obstruction (190) 190
urinary incontinence - drug therapy (190) 190
urinary-bladder (188) 188
rats, sprague-dawley (187) 187
retrospective studies (184) 184
administration, intravesical (180) 180
urge incontinence (180) 180
urodynamics - physiology (177) 177
outlet obstruction (176) 176
urinary bladder, neurogenic - drug therapy (176) 176
management (173) 173
urinary bladder - physiology (170) 170
adolescent (168) 168
urinary bladder, overactive - therapy (161) 161
smooth-muscle (160) 160
spinal cord injury (160) 160
urinary incontinence - physiopathology (159) 159
muscle contraction - drug effects (158) 158
spinal-cord-injury (158) 158
tolterodine (157) 157
health aspects (156) 156
placebo-controlled trial (153) 153
oxybutynin (152) 152
time factors (152) 152
child (151) 151
children (151) 151
urinary bladder, overactive - etiology (150) 150
follow-up studies (149) 149
urinary bladder - metabolism (148) 148
urologic and male genital diseases (147) 147
neuromodulation (146) 146
urinary bladder, neurogenic - physiopathology (146) 146
diagnosis (145) 145
lower urinary tract symptoms (145) 145
expression (144) 144
onabotulinumtoxina (144) 144
injections (143) 143
surgery (139) 139
urothelium (137) 137
clinical neurology (136) 136
safety (136) 136
muscle, smooth - drug effects (135) 135
neurosciences (135) 135
neuromuscular agents - administration & dosage (134) 134
gynecology (132) 132
risk factors (132) 132
young adult (132) 132
prevalence (131) 131
dose-response relationship, drug (130) 130
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (3095) 3095
German (64) 64
French (59) 59
Spanish (27) 27
Czech (6) 6
Polish (6) 6
Turkish (5) 5
Dutch (3) 3
Korean (3) 3
Japanese (2) 2
Italian (1) 1
Lithuanian (1) 1
Portuguese (1) 1
Russian (1) 1
Slovenian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


World Journal of Urology, ISSN 0724-4983, 06/2010, Volume 28, Issue 3, pp. 385 - 390
Journal Article
Neurourology and Urodynamics, ISSN 0733-2467, 08/2017, Volume 36, Issue 6, pp. 1511 - 1518
Aims To evaluate the effects of the beta‐3 adrenoceptor agonist, mirabegron in a mouse model of detrusor overactivity induced by obesity. Methods C57BL/6 male... 
detrusor | overactivity | cAMP | obesity | SELECTIVE BETA-ADRENOCEPTOR AGONIST | NON-VOIDING ACTIVITY | BROWN ADIPOSE-TISSUE | RAT URINARY-BLADDER | CONTRACTILE ACTIVITY | SMOOTH-MUSCLE | MESSENGER-RNA | IN-VIVO | OUTFLOW OBSTRUCTION | UROLOGY & NEPHROLOGY | PHARMACOLOGICAL PROFILE | Body Weight - drug effects | Male | Thiazoles - therapeutic use | Adrenergic beta-3 Receptor Agonists - pharmacology | Muscle, Smooth - drug effects | Urinary Bladder, Overactive - drug therapy | Urinary Bladder, Overactive - physiopathology | Urination - drug effects | Acetanilides - therapeutic use | Cyclic Nucleotide Phosphodiesterases, Type 4 - metabolism | Cyclic AMP - metabolism | Acetanilides - pharmacology | Urinary Bladder - metabolism | Mice, Inbred C57BL | Obesity - physiopathology | Urinary Bladder, Overactive - metabolism | Muscle, Smooth - metabolism | Obesity - metabolism | Carbachol - pharmacology | Adrenergic beta-3 Receptor Agonists - therapeutic use | Animals | Muscle Contraction - drug effects | Muscle, Smooth - physiopathology | Urinary Bladder - physiopathology | Mice, Obese | Urinary Bladder - drug effects | Mice | Thiazoles - pharmacology | Obesity | Carbachol | Analysis | Low density lipoproteins | Body weight | Cyclic adenylic acid | Adenylic acid | Lipoproteins (low density) | Adenosine | Fasting | Body fat | Intracellular levels | Contractility | Bladder | Cyclic AMP | Smooth muscle | Muscle contraction | Potassium chloride | High fat diet | Urinary bladder | Rodents | Protein expression | Adrenergic receptors | Urination | Lipoproteins (high density) | Phosphodiesterase
Journal Article
European Urology, ISSN 0302-2838, 2012, Volume 62, Issue 3, pp. 507 - 514
Abstract Background Emerging data suggest botulinum toxin is an effective treatment for detrusor overactivity (DO), but large studies confirming efficacy and... 
Urology | Incontinence | Detrusor overactivity | Botulinum toxin | Randomised trial | Idiopathic | ANTIMUSCARINIC AGENT | EFFICACY | SAFETY | TOLTERODINE | SOLIFENACIN | URGE URINARY-INCONTINENCE | TOLERABILITY | ANTICHOLINERGIC DRUGS | UROLOGY & NEPHROLOGY | BLADDER | Multivariate Analysis | Humans | Middle Aged | Urodynamics - drug effects | Neuromuscular Agents - therapeutic use | Botulinum Toxins, Type A - administration & dosage | Recovery of Function | Botulinum Toxins, Type A - therapeutic use | Urinary Bladder, Overactive - drug therapy | Time Factors | Urinary Bladder, Overactive - physiopathology | Neuromuscular Agents - administration & dosage | Female | Urinary Incontinence, Urge - drug therapy | Urinary Incontinence, Urge - physiopathology | Odds Ratio | Botulinum Toxins, Type A - adverse effects | Urinary Bladder, Overactive - complications | Urinary Bladder, Overactive - diagnosis | Double-Blind Method | Risk Assessment | Risk Factors | Kaplan-Meier Estimate | Proportional Hazards Models | Linear Models | Treatment Outcome | United Kingdom | Chi-Square Distribution | Urinary Catheterization | Urinary Tract Infections - etiology | Neuromuscular Agents - adverse effects | Urinary Bladder - physiopathology | Urinary Bladder - drug effects | Aged | Urinary Incontinence, Urge - etiology | Administration, Intravesical | Clinical trials
Journal Article
Journal Article
BJU International, ISSN 1464-4096, 11/2019, Volume 124, Issue 5, pp. 870 - 875
Objectives To investigate whether detrusor overactivity (DO) is missed in a relevant percentage of patients if the urodynamic investigation (UDI) is stopped at... 
bladder capacity | routine diagnostic tests | urodynamics | neuro‐urology | urinary bladder | detrusor overactivity | Bladder | Urinary tract | Autonomic nervous system | Urogenital system | Investigations
Journal Article
Journal Article
Journal Article